Literature DB >> 28846077

Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts.

Michael I Koukourakis1, Dimitra Kalamida1, Achilleas G Mitrakas1, Maria Liousia2, Stamatia Pouliliou1, Efthimios Sivridis2, Alexandra Giatromanolaki2.   

Abstract

Cooperation of cancer cells with stromal cells, such as cancer-associated fibroblasts (CAFs), has been revealed as a mechanism sustaining cancer cell survival and growth. In the current study, we focus on the metabolic interactions of MRC5 lung fibroblasts with lung cancer cells (A549 and H1299) using co-culture experiments and studying changes of the metabolic protein expression profile and of their growth and migration abilities. Using western blotting, confocal microscopy and RT-PCR, we observed that in co-cultures MRC5 respond by upregulating pyruvate dehydrogenase (PDH) and the monocarboxylate transporter MCT1. In contrast, cancer cells increase the expression of glucose transporters (GLUT1), LDH5, PDH kinase and the levels of phosphorylated/inactivated pPDH. H1299 cells growing in the same culture medium with fibroblasts exhibit a 'metastasis-like' phenomenon by forming nests within the fibroblast area. LDH5 and pPDH were drastically upregulated in these nests. The growth rate of both MRC5 and cancer cells increased in co-cultures. Suppression of LDHA or PDK1 in cancer cells abrogates the stimulatory signal from cancer cells to fibroblasts. Incubation of MRC5 fibroblasts with lactate resulted in an increase of LDHB and of PDH expression. Silencing of PDH gene in fibroblasts, or silencing of PDK1 or LDHA gene in tumor cells, impedes cancer cell's migration ability. Overall, a metabolic cooperation between lung cancer cells and fibroblasts has been confirmed in the context of direct Warburg effect, thus the fibroblasts reinforce aerobic metabolism to support the intensified anaerobic glycolytic pathways exploited by cancer cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28846077     DOI: 10.1038/labinvest.2017.79

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.

Authors:  Alexandra Giatromanolaki; Michael I Koukourakis; Anastasios Koutsopoulos; Savvas Mendrinos; Efthimios Sivridis
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

3.  Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro.

Authors:  Sun-Ah Kim; Eun Kyung Lee; Hyo-Jeong Kuh
Journal:  Exp Cell Res       Date:  2015-05-28       Impact factor: 3.905

4.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 6.  The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation.

Authors:  A P Halestrap; N T Price
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

Review 7.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

Authors:  Maria L Macheda; Suzanne Rogers; James D Best
Journal:  J Cell Physiol       Date:  2005-03       Impact factor: 6.384

8.  Stimulation of fibroblast proliferation by lactate-mediated oxidants.

Authors:  Silvia Wagner; M Zamirul Hussain; Thomas K Hunt; Biljana Bacic; Horst D Becker
Journal:  Wound Repair Regen       Date:  2004 May-Jun       Impact factor: 3.617

9.  Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.

Authors:  Sung-Hyun Kim; Chungyoul Choe; Yong-Sung Shin; Mi-Jin Jeon; So-Jung Choi; Jinseon Lee; Gab-Yong Bae; Hyuk-Jin Cha; Jhingook Kim
Journal:  Anticancer Res       Date:  2013-05       Impact factor: 2.480

10.  Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane.

Authors:  Tamir Epstein; Liping Xu; Robert J Gillies; Robert A Gatenby
Journal:  Cancer Metab       Date:  2014-06-05
View more
  12 in total

1.  An in vivo Like Micro-Carcinoma Model.

Authors:  Sandra Camargo; Yulia Shamis; Assaf Assis; Eduardo Mitrani
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

2.  Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.

Authors:  Jing Chen; Shunwang Cao; Bo Situ; Juan Zhong; Yanwei Hu; Shufen Li; Jinlan Huang; Jiasen Xu; Shiyang Wu; Jinduan Lin; Qianwen Zhao; Zhen Cai; Lei Zheng; Qian Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-06-28

3.  Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis.

Authors:  Eva Schruf; Victoria Schroeder; Christian A Kuttruff; Sabine Weigle; Martin Krell; Maryke Benz; Tom Bretschneider; Alexander Holweg; Michael Schuler; Manfred Frick; Paul Nicklin; James P Garnett; Mirko C Sobotta
Journal:  Respir Res       Date:  2019-05-09

Review 4.  Monocarboxylate transporters in cancer.

Authors:  Valéry L Payen; Erica Mina; Vincent F Van Hée; Paolo E Porporato; Pierre Sonveaux
Journal:  Mol Metab       Date:  2019-07-27       Impact factor: 7.422

Review 5.  Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.

Authors:  Dilara Kiran; Randall J Basaraba
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 6.073

6.  Bioengineered Cystinotic Kidney Tubules Recapitulate a Nephropathic Phenotype.

Authors:  Elena Sendino Garví; Rosalinde Masereeuw; Manoe J Janssen
Journal:  Cells       Date:  2022-01-05       Impact factor: 6.600

7.  UCP2 - Taking the heat out of P-glycoprotein?

Authors:  Richard Callaghan; Mary Board
Journal:  Cancer Drug Resist       Date:  2021-06-19

8.  Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis.

Authors:  Yuanshan Yao; Zheng Li; Wen Gao
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

9.  Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.

Authors:  Kun Dai; Megumu Tanaka; Akiko Kamiyoshi; Takayuki Sakurai; Yuka Ichikawa-Shindo; Hisaka Kawate; Nanqi Cui; Yangxuan Wei; Masaaki Tanaka; Shinji Kakihara; Shuhei Matsui; Takayuki Shindo
Journal:  Oncogene       Date:  2019-11-21       Impact factor: 9.867

10.  Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion.

Authors:  R Commander; C Wei; A Sharma; J K Mouw; L J Burton; E Summerbell; D Mahboubi; R J Peterson; J Konen; W Zhou; Y Du; H Fu; M Shanmugam; A I Marcus
Journal:  Nat Commun       Date:  2020-03-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.